250 mgs. / 1 cc. vials or preloads. Sustanon 250 is one of the most popular steroids and for good reason. It is precisely set up to give you results for up to a month after injection because each of the testosterones that make up Sustanon 250 stay active in the body for differing time periods. It gives you almost instant results that you can feel since it will hit you about 3 hours after your first injection. The reason for this is the fast acting properties of the testosterone propionate that is in it. The testosterone phenylpropionate and testosterone isocaproate will typically stay active for about 2-3 weeks each and the testosterone decanoate stays active in the body for up to a month. This combination is what gives Sustanon 250 its quick onset which continues to hit you for about 4 weeks after the last injection. This drug also degrades and tapers nicely for the same reasons. Some people will argue that Sustanon is good because since it is made up of multiple types of testosterone, that it "will hit multiple androgen receptors." This could not be further from the truth. You only have one type of androgen receptor. All steroids hit the same androgen receptor regardless of what you are taking.
Both sterile and non-sterile compounding are legal provided the medicines are provided for a particular patient for therapeutic application to that patient, and the compounded product is supplied on or from the compounding pharmacy premises.  There are additional requirements for sterile compounding. Not only must a laminar flow cabinet [laminar flow hood] be used, but the environment in which the hood is located must be strictly controlled for microbial and particulate contamination and all procedures, equipment and personnel must be validated to ensure the safe preparation of sterile products. In non-sterile compounding, a powder containment hood is required when any hazardous material (. hormones) are prepared or when there is a risk of cross-contamination of the compounded product. Pharmacists preparing compounded products must comply with these requirements and others published in the Australian Pharmaceutical Formulary & Handbook.